CMS-1676-F 413
TABLE 12: CY 2018 Work RVUs for New, Revised and Potentially Misvalued Codes
HCPCS
Code Long Descriptor
CY 2017
Work
RVU
Proposed
CY 2018
Work
RVU
Final
CY
2018
Work
RVU
CMS Work
Time
Refinement
00731
Anesthesia for upper gastrointestinal
endoscopic procedures, endoscope introduced
proximal to duodenum; not otherwise specified
NEW 0.00 0.00 No
00732
Anesthesia for upper gastrointestinal
endoscopic procedures, endoscope introduced
proximal to duodenum; endoscopic retrograde
cholangiopancreatography (ERCP)
NEW 0.00 0.00 No
00811
Anesthesia for lower intestinal endoscopic
procedures, endoscope introduced distal to
duodenum; not otherwise specified
NEW 0.00 0.00 No
00812
Anesthesia for lower intestinal endoscopic
procedures, endoscope introduced distal to
duodenum; screening colonoscopy
NEW 0.00 0.00 No
00813
Anesthesia for combined upper and lower
gastrointestinal endoscopic procedures,
endoscope introduced both proximal to and
distal to the duodenum
NEW 0.00 0.00 No
10040
Acne surgery (eg, marsupialization, opening or
removal of multiple milia, comedones, cysts,
pustules)
1.21 0.91 0.91 No
15730 Midface flap (ie, zygomaticofacial flap) with
preservation of vascular pedicle(s) NEW 13.50 13.50 No
15733
Muscle, myocutaneous, or fasciocutaneous flap;
head and neck with named vascular pedicle (ie,
buccinators, genioglossus, temporalis, masseter,
sternocleidomastoid, levator scapulae)
NEW 15.68 15.68 No
15734 Muscle, myocutaneous, or fasciocutaneous flap;
trunk 19.86 23.00 23.00 No
15736 Muscle, myocutaneous, or fasciocutaneous flap;
upper extremity 17.04 17.04 17.04 No
15738 Muscle, myocutaneous, or fasciocutaneous flap;
lower extremity 19.04 19.04 19.04 No
19294
Preparation of tumor cavity with placement of a
radiation therapy applicator for intraoperative
radiation therapy (IORT) concurrent with
partial mastectomy
NEW 3.00 3.00 No
19303 Mastectomy, simple, complete 15.85 15.00 15.00 No
20939
Bone marrow aspiration for bone grafting,
spine surgery only, through separate skin or
fascial incision
NEW 1.16 1.16 No
29445 Application of rigid total contact leg cast 1.78 1.78 1.78 No
29580 Strapping; Unna boot 0.55 0.55 0.55 No
29581 Application of multi-layer compression system;
leg (below knee), including ankle and foot 0.25 0.60 0.60 No
30140 Submucous resection inferior turbinate, partial
or complete, any method 3.57 3.00 3.00 No
30901 Control nasal hemorrhage, anterior, simple
(limited cautery and/or packing) any method 1.10 1.10 1.10 No
CMS-1676-F 414
HCPCS
Code Long Descriptor
CY 2017
Work
RVU
Proposed
CY 2018
Work
RVU
Final
CY
2018
Work
RVU
CMS Work
Time
Refinement
30903 Control nasal hemorrhage, anterior, complex
(extensive cautery and/or packing) any method 1.54 1.54 1.54 No
30905
Control nasal hemorrhage, posterior, with
posterior nasal packs and/or cautery, any
method; initial
1.97 1.97 1.97 No
30906
Control nasal hemorrhage, posterior, with
posterior nasal packs and/or cautery, any
method; subsequent
2.45 2.45 2.45 No
31241 Nasal/sinus endoscopy, surgical; with ligation
of sphenopalatine artery NEW 8.00 8.00 No
31253
Nasal/sinus endoscopy, surgical with
ethmoidectomy; total (anterior and posterior),
including frontal sinus exploration, with
removal of tissue from frontal sinus, when
performed
NEW 9.00 9.00 No
31254 Nasal/sinus endoscopy, surgical with
ethmoidectomy; partial (anterior) 4.64 4.27 4.27 No
31255 Nasal/sinus endoscopy, surgical with
ethmoidectomy; total (anterior and posterior) 6.95 5.75 5.75 No
31256 Nasal/sinus endoscopy, surgical, with maxillary
antrostomy 3.29 3.11 3.11 No
31257
Nasal/sinus endoscopy, surgical with
ethmoidectomy; total (anterior and posterior),
including sphenoidotomy
NEW 8.00 8.00 No
31259
Nasal/sinus endoscopy, surgical with
ethmoidectomy; total (anterior and posterior),
including sphenoidotomy, with removal of
tissue from the sphenoid sinus
NEW 8.48 8.48 No
31267
Nasal/sinus endoscopy, surgical, with maxillary
antrostomy; with removal of tissue from
maxillary sinus
5.45 4.68 4.68 No
31276
Nasal/sinus endoscopy, surgical, with frontal
sinus exploration, including removal of tissue
from frontal sinus, when performed
8.84 6.75 6.75 No
31287 Nasal/sinus endoscopy, surgical, with
sphenoidotomy 3.91 3.50 3.50 No
31288
Nasal/sinus endoscopy, surgical, with
sphenoidotomy; with removal of tissue from the
sphenoid sinus
4.57 4.10 4.10 No
31295
Nasal/sinus endoscopy, surgical; with dilation
of maxillary sinus ostium (eg, balloon dilation),
transnasal or canine fossa
2.70 2.70 2.70 No
31296 Nasal/sinus endoscopy, surgical; with dilation
of frontal sinus ostium (eg, balloon dilation) 3.29 3.10 3.10 No
31297 Nasal/sinus endoscopy, surgical; with dilation
of sphenoid sinus ostium (eg, balloon dilation) 2.64 2.44 2.44 No
31298
Nasal/sinus endoscopy, surgical; with dilation
of frontal and sphenoid sinus ostia (eg, balloon
dilation)
NEW 4.50 4.50 No
31600 Tracheostomy, planned (separate procedure) 7.17 5.56 5.56 No
CMS-1676-F 415
HCPCS
Code Long Descriptor
CY 2017
Work
RVU
Proposed
CY 2018
Work
RVU
Final
CY
2018
Work
RVU
CMS Work
Time
Refinement
31601 Tracheostomy, planned (separate procedure);
younger than 2 years 4.44 8.00 8.00 No
31603 Tracheostomy, emergency procedure;
transtracheal 4.14 6.00 6.00 No
31605 Tracheostomy, emergency procedure;
cricothyroid membrane 3.57 6.45 6.45 No
31610 Tracheostomy, fenestration procedure with skin
flaps 9.38 12.00 12.00 No
31645
Bronchoscopy, rigid or flexible, including
fluoroscopic guidance, when performed with
therapeutic aspiration of tracheobronchial tree,
initial
2.91 2.88 2.88 No
31646
Bronchoscopy, rigid or flexible, including
fluoroscopic guidance, when performed with
therapeutic aspiration of tracheobronchial tree,
subsequent, same hospital stay
2.47 2.78 2.78 No
32994
Ablation therapy for reduction or eradication of
1 or more pulmonary tumor(s) including pleura
or chest wall when involved by tumor
extension, percutaneous, including imaging
guidance when performed, unilateral;
cryoablation
NEW 9.03 9.03 No
32998
Ablation therapy for reduction or eradication of
1 or more pulmonary tumor(s) including pleura
or chest wall when involved by tumor
extension, percutaneous, including imaging
guidance when performed, unilateral;
radiofrequency
5.68 9.03 9.03 No
33927
Implantation of a total replacement heart
system (artificial heart) with recipient
cardiectomy
NEW 49.00 49.00 No
33928
Removal of a total replacement heart system
(artificial heart) for heart transplantation NEW C C No
33929
Removal and replacement of total replacement
heart system (artificial heart) NEW C C No
34701
Endovascular repair of infrarenal aorta by
deployment of an aorto-aortic tube endograft
including pre-procedure sizing and device
selection, all nonselective catheterization(s), all
associated radiological supervision and
interpretation, all endograft extension(s) placed
in the aorta from the level of the renal arteries
to the aortic bifurcation, and all
angioplasty/stenting performed from the level
of the renal arteries to the aortic bifurcation; for
other than rupture (eg, for aneurysm,
pseudoaneurysm, dissection, penetrating ulcer)
NEW 23.71 23.71 No
34702
Endovascular repair of infrarenal aorta by
deployment of an aorto-aortic tube endograft
including pre-procedure sizing and device
NEW 36.00 36.00 No
CMS-1676-F 416
HCPCS
Code Long Descriptor
CY 2017
Work
RVU
Proposed
CY 2018
Work
RVU
Final
CY
2018
Work
RVU
CMS Work
Time
Refinement
selection, all nonselective catheterization(s), all
associated radiological supervision and
interpretation, all endograft extension(s) placed
in the aorta from the level of the renal arteries
to the aortic bifurcation, and all
angioplasty/stenting performed from the level
of the renal arteries to the aortic bifurcation; for
rupture including temporary aortic and/or iliac
balloon occlusion when performed (eg, for
aneurysm, pseudoaneurysm, dissection,
penetrating ulcer, traumatic disruption)
34703
Endovascular repair of infrarenal aorta and/or
iliac artery(ies) by deployment of an aorto-
uniiliac endograft including pre-procedure
sizing and device selection, all nonselective
catheterization(s), all associated radiological
supervision and interpretation, all endograft
extension(s) placed in the aorta from the level
of the renal arteries to the iliac bifurcation, and
all angioplasty/stenting performed from the
level of the renal arteries to the iliac
bifurcation; for other than rupture (eg, for
aneurysm, pseudoaneurysm, dissection,
penetrating ulcer)
NEW 26.52 26.52 No
34704
Endovascular repair of infrarenal aorta and/or
iliac artery(ies) by deployment of an aorto-
uniiliac endograft including pre-procedure
sizing and device selection, all nonselective
catheterization(s), all associated radiological
supervision and interpretation, all endograft
extension(s) placed in the aorta from the level
of the renal arteries to the iliac bifurcation, and
all angioplasty/stenting performed from the
level of the renal arteries to the iliac
bifurcation; for rupture including temporary
aortic and/or iliac balloon occlusion when
performed (eg, for aneurysm, pseudoaneurysm,
dissection, penetrating ulcer, traumatic
disruption)
NEW 45.00 45.00 No
34705
Endovascular repair of infrarenal aorta and/or
iliac artery(ies) by deployment of an aorto-
biiliac endograft including pre-procedure sizing
and device selection, all nonselective
catheterization(s), all associated radiological
supervision and interpretation, all endograft
extension(s) placed in the aorta from the level
of the renal arteries to the iliac bifurcation, and
all angioplasty/stenting performed from the
level of the renal arteries to the iliac
bifurcation; for other than rupture (eg, for
aneurysm, pseudoaneurysm, dissection,
NEW 29.58 29.58 No
CMS-1676-F 417
HCPCS
Code Long Descriptor
CY 2017
Work
RVU
Proposed
CY 2018
Work
RVU
Final
CY
2018
Work
RVU
CMS Work
Time
Refinement
penetrating ulcer)
34706
Endovascular repair of infrarenal aorta and/or
iliac artery(ies) by deployment of an aorto-
biiliac endograft including pre-procedure sizing
and device selection, all nonselective
catheterization(s), all associated radiological
supervision and interpretation, all endograft
extension(s) placed in the aorta from the level
of the renal arteries to the iliac bifurcation, and
all angioplasty/stenting performed from the
level of the renal arteries to the iliac
bifurcation; for rupture including temporary
aortic and/or iliac balloon occlusion when
performed (eg, for aneurysm, pseudoaneurysm,
dissection, penetrating ulcer, traumatic
disruption)
NEW 45.00 45.00 No
34707
Endovascular repair of iliac artery by
deployment of an ilio-iliac tube endograft
including pre-procedure sizing and device
selection, all nonselective catheterization(s), all
associated radiological supervision and
interpretation, and all endograft extension(s)
proximally to the aortic bifurcation and distally
to the iliac bifurcation, and treatment zone
angioplasty/stenting when performed,
unilateral; for other than rupture (eg, for
aneurysm, pseudoaneurysm, dissection,
arteriovenous malformation)
NEW 22.28 22.28 No
34708
Endovascular repair of iliac artery by
deployment of an ilio-iliac tube endograft
including pre-procedure sizing and device
selection, all nonselective catheterization(s), all
associated radiological supervision and
interpretation, and all endograft extension(s)
proximally to the aortic bifurcation and distally
to the iliac bifurcation, and treatment zone
angioplasty/stenting when performed,
unilateral; for rupture including temporary
aortic and/or iliac balloon occlusion when
performed (eg, for aneurysm, pseudoaneurysm,
dissection, arteriovenous malformation,
traumatic disruption)
NEW 36.50 36.50 No
34709
Placement of extension prosthesis(es) distal to
the common iliac artery(ies) or proximal to the
renal artery(ies) for endovascular repair of
infrarenal abdominal aortic or iliac aneurysm,
false aneurysm, dissection, penetrating ulcer,
including pre-procedure sizing and device
selection, all nonselective catheterization(s), all
associated radiological supervision and
interpretation, and treatment zone
NEW 6.50 6.50 No
CMS-1676-F 418
HCPCS
Code Long Descriptor
CY 2017
Work
RVU
Proposed
CY 2018
Work
RVU
Final
CY
2018
Work
RVU
CMS Work
Time
Refinement
angioplasty/stenting when performed, per
vessel treated
34710
Delayed placement of distal or proximal
extension prosthesis for endovascular repair of
infrarenal abdominal aortic or iliac aneurysm,
false aneurysm, dissection, endoleak, or
endograft migration, including pre-procedure
sizing and device selection, all nonselective
catheterization(s), all associated radiological
supervision and interpretation, and treatment
zone angioplasty/stenting when performed;
initial vessel treated
NEW 15.00 15.00 No
34711
Delayed placement of distal or proximal
extension prosthesis for endovascular repair of
infrarenal abdominal aortic or iliac aneurysm,
false aneurysm, dissection, endoleak, or
endograft migration, including pre-procedure
sizing and device selection, all nonselective
catheterization(s), all associated radiological
supervision and interpretation, and treatment
zone angioplasty/stenting when performed;
each additional vessel treated
NEW 6.00 6.00 No
34712
Transcatheter delivery of enhanced fixation
device(s) to the endograft (eg, anchor, screw,
tack) and all associated radiological supervision
and interpretation
NEW 12.00 12.00 No
34713
Percutaneous access and closure of femoral
artery for delivery of endograft through a large
sheath (12 French or larger), including
ultrasound guidance, when performed,
unilateral
NEW 2.50 2.50 No
34714
Open femoral artery exposure with creation of
conduit for delivery of endovascular prosthesis
or for establishment of cardiopulmonary
bypass, by groin incision, unilateral
NEW 5.25 5.25 No
34715
Open axillary/subclavian artery exposure for
delivery of endovascular prosthesis by
infraclavicular or supraclavicular incision,
unilateral
NEW 6.00 6.00 No
34716
Open axillary/subclavian artery exposure with
creation of conduit for delivery of endovascular
prosthesis or for establishment of
cardiopulmonary bypass, by infraclavicular or
supraclavicular incision, unilateral
NEW 7.19 7.19 No
34812
Open femoral artery exposure for delivery of
endovascular prosthesis by groin incision,
unilateral
6.74 4.13 4.13 No
34820
Open iliac artery exposure for delivery of
endovascular prosthesis or iliac occlusion by
abdominal or retroperitoneal incision, unilateral
9.74 7.00 7.00 No
CMS-1676-F 419
HCPCS
Code Long Descriptor
CY 2017
Work
RVU
Proposed
CY 2018
Work
RVU
Final
CY
2018
Work
RVU
CMS Work
Time
Refinement
34833
Open iliac artery exposure with creation of
conduit for delivery of endovascular prosthesis
or for establishment of cardiopulmonary
bypass, by abdominal or retroperitoneal
incision, unilateral
11.98 8.16 8.16 No
34834 Open brachial artery exposure for delivery of
endovascular prosthesis unilateral 5.34 2.65 2.65 No
36215
Selective catheter placement, arterial system;
each first order thoracic or brachiocephalic
branch, within a vascular family
4.67 4.17 4.17 No
36216
Selective catheter placement, arterial system;
initial second order thoracic or brachiocephalic
branch, within a vascular family
5.27 5.27 5.27 No
36217
Selective catheter placement, arterial system;
initial third order or more selective thoracic or
brachiocephalic branch, within a vascular
family
6.29 6.29 6.29 No
36218
Selective catheter placement, arterial system;
additional second order, third order, and
beyond, thoracic or brachiocephalic branch,
within a vascular family
1.01 1.01 1.01 No
36465
Injection of non-compounded foam sclerosant
with ultrasound compression maneuvers to
guide dispersion of the injectate, inclusive of all
imaging guidance and monitoring; single
incompetent extremity truncal vein (eg, great
saphenous vein, accessory saphenous vein)
NEW 2.35 2.35 No
36466
Injection of non-compounded foam sclerosant
with ultrasound compression maneuvers to
guide dispersion of the injectate, inclusive of all
imaging guidance and monitoring; multiple
incompetent truncal veins (eg, great saphenous
vein, accessory saphenous vein), same leg
NEW 3.00 3.00 No
36470 Injection of sclerosant; single incompetent vein
(other than telangiectasia) 1.10 0.75 0.75 No
36471 Injection of sclerosant; multiple incompetent
veins (other than telangiectasia), same leg 1.65 1.50 1.50 No
36482
Endovenous ablation therapy of incompetent
vein, extremity, by transcatheter delivery of a
chemical adhesive (eg, cyanoacrylate) remote
from the access site, inclusive of all imaging
guidance and monitoring, percutaneous; first
vein treated
NEW 3.50 3.50 No
36483
Endovenous ablation therapy of incompetent
vein, extremity, by transcatheter delivery of a
chemical adhesive (eg, cyanoacrylate) remote
from the access site, inclusive of all imaging
guidance and monitoring, percutaneous;
subsequent vein(s) treated in a single extremity,
each through separate access sites
NEW 1.75 1.75 No
CMS-1676-F 420
HCPCS
Code Long Descriptor
CY 2017
Work
RVU
Proposed
CY 2018
Work
RVU
Final
CY
2018
Work
RVU
CMS Work
Time
Refinement
36511 Therapeutic apheresis; for white blood cells 1.74 2.00 2.00 No
36512 Therapeutic apheresis; for red blood cells 1.74 2.00 2.00 No
36513 Therapeutic apheresis; for platelets 1.74 2.00 2.00 No
36514 Therapeutic apheresis; for plasma pheresis 1.74 1.81 1.81 No
36516
Therapeutic apheresis; with extracorporeal
selective adsorption or selective filtration and
plasma reinfusion
1.22 1.56 1.56 No
36522 Photopheresis, extracorporeal 1.67 1.75 1.75 No
36555
Insertion of non-tunneled centrally inserted
central venous catheter; younger than 5 years of
age
2.43 1.93 1.93 No
36556 Insertion of non-tunneled centrally inserted
central venous catheter; age 5 years or older 2.50 1.75 1.75 No
36569
Insertion of peripherally inserted central venous
catheter (PICC), without subcutaneous port or
pump; age 5 years or older
1.82 1.70 1.70 No
36620
Arterial catheterization or cannulation for
sampling, monitoring or transfusion (separate
procedure); percutaneous
1.15 1.00 1.00 No
36901
Introduction of needle(s) and/or catheter(s),
dialysis circuit, with diagnostic angiography of
the dialysis circuit, including all direct
puncture(s) and catheter placement(s),
injection(s) of contrast, all necessary imaging
from the arterial anastomosis and adjacent
artery through entire venous outflow including
the inferior or superior vena cava, fluoroscopic
guidance, radiological supervision and
interpretation and image documentation and
report;
2.82 - 3.36 No
36902
Introduction of needle(s) and/or catheter(s),
dialysis circuit, with diagnostic angiography of
the dialysis circuit, including all direct
puncture(s) and catheter placement(s),
injection(s) of contrast, all necessary imaging
from the arterial anastomosis and adjacent
artery through entire venous outflow including
the inferior or superior vena cava, fluoroscopic
guidance, radiological supervision and
interpretation and image documentation and
report; with transluminal balloon angioplasty,
peripheral dialysis segment, including all
imaging and radiological supervision and
interpretation necessary to perform the
angioplasty
4.24 - 4.83 No
36903
Introduction of needle(s) and/or catheter(s),
dialysis circuit, with diagnostic angiography of
the dialysis circuit, including all direct
puncture(s) and catheter placement(s),
injection(s) of contrast, all necessary imaging
5.85 - 6.39 No
CMS-1676-F 421
HCPCS
Code Long Descriptor
CY 2017
Work
RVU
Proposed
CY 2018
Work
RVU
Final
CY
2018
Work
RVU
CMS Work
Time
Refinement
from the arterial anastomosis and adjacent
artery through entire venous outflow including
the inferior or superior vena cava, fluoroscopic
guidance, radiological supervision and
interpretation and image documentation and
report; with transcatheter placement of
intravascular stent(s), peripheral dialysis
segment, including all imaging and radiological
supervision and interpretation necessary to
perform the stenting, and all angioplasty within
the peripheral dialysis segment
36904
Percutaneous transluminal mechanical
thrombectomy and/or infusion for
thrombolysis, dialysis circuit, any method,
including all imaging and radiological
supervision and interpretation, diagnostic
angiography, fluoroscopic guidance, catheter
placement(s), and intraprocedural
pharmacological thrombolytic injection(s);
6.73 - 7.50 No
36905
Percutaneous transluminal mechanical
thrombectomy and/or infusion for
thrombolysis, dialysis circuit, any method,
including all imaging and radiological
supervision and interpretation, diagnostic
angiography, fluoroscopic guidance, catheter
placement(s), and intraprocedural
pharmacological thrombolytic injection(s); with
transluminal balloon angioplasty, peripheral
dialysis segment, including all imaging and
radiological supervision and interpretation
necessary to perform the angioplasty
8.46 - 9.00 No
36906
Percutaneous transluminal mechanical
thrombectomy and/or infusion for
thrombolysis, dialysis circuit, any method,
including all imaging and radiological
supervision and interpretation, diagnostic
angiography, fluoroscopic guidance, catheter
placement(s), and intraprocedural
pharmacological thrombolytic injection(s); with
transcatheter placement of intravascular
stent(s), peripheral dialysis segment, including
all imaging and radiological supervision and
interpretation necessary to perform the stenting,
and all angioplasty within the peripheral
dialysis circuit
9.88 - 10.42 No
36907
Transluminal balloon angioplasty, central
dialysis segment, performed through dialysis
circuit, including all imaging and radiological
supervision and interpretation required to
perform the angioplasty
2.48 - 3.00 No
36908 Transcatheter placement of intravascular 3.73 - 4.25 No
CMS-1676-F 422
HCPCS
Code Long Descriptor
CY 2017
Work
RVU
Proposed
CY 2018
Work
RVU
Final
CY
2018
Work
RVU
CMS Work
Time
Refinement
stent(s), central dialysis segment, performed
through dialysis circuit, including all imaging
radiological supervision and interpretation
required to perform the stenting, and all
angioplasty in the central dialysis segment
36909
Dialysis circuit permanent vascular
embolization or occlusion (including main
circuit or any accessory veins), endovascular,
including all imaging and radiological
supervision and interpretation necessary to
complete the intervention
3.48 - 4.12 No
38220 Diagnostic bone marrow; aspiration(s) 1.08 1.20 1.20 No
38221 Diagnostic bone marrow; biopsy(ies) 1.37 1.28 1.28 No
38222 Diagnostic bone marrow; biopsy(ies) and
aspiration(s) NEW 1.44 1.44 No
38573
Laparoscopy, surgical; with bilateral total
pelvic lymphadenectomy and peri-aortic lymph
node sampling peritoneal washings, peritoneal
biopsy(s), omentectomy, and diaphragmatic
washings, including biopsy(s) when performed
NEW 20.00 20.00 No
43107
Total or near total esophagectomy, without
thoracotomy; with pharyngogastrostomy or
cervical esophagogastrostomy, with or without
pyloroplasty (transhiatal)
44.18 52.05 52.05 No
43112
Total or near total esophagectomy, with
thoracotomy; with pharyngogastrostomy or
cervical esophagogastrostomy, with or without
pyloroplasty (ie, McKeown esophagectomy, or
tri-incisional esophagectomy)
47.48 62.00 62.00 No
43117
Partial esophagectomy, distal two-thirds, with
thoracotomy and separate abdominal incision,
with or without proximal gastrectomy; with
thoracic esophagogastrostomy, with or without
pyloroplasty (Ivor Lewis)
43.65 57.50 57.50 No
43286
Esophagectomy, total or near total, with
laparoscopic mobilization of the abdominal and
mediastinal esophagus and proximal
gastrectomy, with laparoscopic pyloric drainage
procedure if performed, with open cervical
pharyngogastrostomy or esophagogastrostomy
(ie, laparoscopic transhiatal esophagectomy)
NEW 55.00 55.00 No
43287
Esophagectomy, distal two-thirds, with
laparoscopic mobilization of the abdominal and
lower mediastinal esophagus and proximal
gastrectomy, with laparoscopic pyloric drainage
procedure if performed, with separate
thoracoscopic mobilization of the middle and
upper mediastinal esophagus and thoracic
esophagogastrostomy (ie, laparoscopic
thoracoscopic esophagectomy, Ivor Lewis
NEW 63.00 63.00 No
CMS-1676-F 423
HCPCS
Code Long Descriptor
CY 2017
Work
RVU
Proposed
CY 2018
Work
RVU
Final
CY
2018
Work
RVU
CMS Work
Time
Refinement
esophagectomy)
43288
Esophagectomy, total or near total, with
thoracoscopic mobilization of the upper,
middle, and lower mediastinal esophagus, with
separate laparoscopic proximal gastrectomy,
with laparoscopic pyloric drainage procedure if
performed, with open cervical
pharyngogastrostomy or esophagogastrostomy
(ie, thoracoscopic, laparoscopic and cervical
incision esophagectomy, McKeown
esophagectomy, tri-incisional esophagectomy)
NEW 66.42 66.42 No
51798
Measurement of post-voiding residual urine
and/or bladder capacity by ultrasound, non-
imaging
0.00 0.00 0.00 No
52601
Transurethral electrosurgical resection of
prostate, including control of postoperative
bleeding, complete (vasectomy, meatotomy,
cystourethroscopy, urethral calibration and/or
dilation, and internal urethrotomy are included)
15.26 13.16 13.16 No
55874
Transperineal placement of biodegradable
material, peri-prostatic, single or multiple
injection(s), including image guidance, when
performed
NEW 3.03 3.03 No
57240
Anterior colporrhaphy, repair of cystocele with
or without repair of urethrocele, including
cystourethroscopy, when performed
11.50 10.08 10.08 No
57250 Posterior colporrhaphy, repair of rectocele with
or without perineorrhaphy 11.50 10.08 10.08 No
57260 Combined anteroposterior colporrhaphy,
including cystourethroscopy, when performed 14.44 13.25 13.25 No
57265
Combined anteroposterior colporrhaphy,
including cystourethroscopy, when performed;
with enterocele repair
15.94 15.00 15.00 No
58575
Laparoscopy, surgical, total hysterectomy; with
or without salpingo-oophorectomy, unilateral or
bilateral, with resection of malignancy (tumor
debulking), with omentectomy
NEW 32.60 32.60 No
64418 Injection, anesthetic agent; suprascapular nerve 1.32 1.10 1.10 No
64553 Percutaneous implantation of neurostimulator
electrode array; cranial nerve 2.36 6.13 6.13 No
64555
Percutaneous implantation of neurostimulator
electrode array; peripheral nerve (excludes
sacral nerve)
2.32 5.76 5.76 No
64910 Nerve repair; with synthetic conduit or vein
allograft (eg, nerve tube), each nerve 11.39 10.52 10.52 No
64911 Nerve repair; with autogenous vein graft
(includes harvest of vein graft), each nerve 14.39 14.00 14.00 No
64912 Nerve repair; with nerve allograft, each nerve,
first strand (cable) NEW 12.00 12.00 No
64913 Nerve repair; with nerve allograft, each NEW 3.00 3.00 No
CMS-1676-F 424
HCPCS
Code Long Descriptor
CY 2017
Work
RVU
Proposed
CY 2018
Work
RVU
Final
CY
2018
Work
RVU
CMS Work
Time
Refinement
additional strand
67820 Correction of trichiasis; epilation, by forceps
only 0.71 0.32 0.32 No
70490 Computed tomography, soft tissue neck;
without contrast material 1.28 1.28 1.28 No
70491 Computed tomography, soft tissue neck; with
contrast material(s) 1.38 1.38 1.38 No
70492
Computed tomography, soft tissue neck;
without contrast material followed by contrast
material(s) and further sections
1.45 1.62 1.62 No
70544 Magnetic resonance angiography, head; without
contrast material(s) 1.20 1.20 1.20 No
70545 Magnetic resonance angiography, head; with
contrast material(s) 1.20 1.20 1.20 No
70546
Magnetic resonance angiography, head; without
contrast material(s), followed by contrast
material(s) and further sequences
1.80 1.48 1.48 No
70547 Magnetic resonance angiography, neck; without
contrast material(s) 1.20 1.20 1.20 No
70548 Magnetic resonance angiography, neck; with
contrast material(s) 1.20 1.50 1.50 No
70549
Magnetic resonance angiography, neck; without
contrast material(s), followed by contrast
material(s) and further sequences
1.80 1.80 1.80 No
71045 Radiologic examination, chest; single view NEW 0.18 0.18 No
71046 Radiologic examination, chest; 2 views NEW 0.22 0.22 No
71047 Radiologic examination, chest; 3 views NEW 0.27 0.27 No
71048 Radiologic examination, chest; 4 or more views NEW 0.31 0.31 No
71100 Radiologic examination, ribs, unilateral; 2
views 0.22 0.22 0.22 No
71101
Radiologic examination, ribs, unilateral;
including posteroanterior chest, minimum of 3
views
0.27 0.27 0.27 No
71110 Radiologic examination, ribs, bilateral; 3 views 0.27 0.29 0.29 No
71111
Radiologic examination, ribs, bilateral;
including posteroanterior chest, minimum of 4
views
0.32 0.32 0.32 No
71250 Computed tomography, thorax; without
contrast material 1.02 1.16 1.16 No
71260 Computed tomography, thorax; with contrast
material(s) 1.24 1.24 1.24 No
71270
Computed tomography, thorax; without
contrast material, followed by contrast
material(s) and further sections
1.38 1.38 1.38 No
72195 Magnetic resonance (eg, proton) imaging,
pelvis; without contrast material(s) 1.46 1.46 1.46 No
72196 Magnetic resonance (eg, proton) imaging,
pelvis; with contrast material(s) 1.73 1.73 1.73 No
72197 Magnetic resonance (eg, proton) imaging,
pelvis; without contrast material(s), followed by 2.26 2.20 2.20 No
CMS-1676-F 425
HCPCS
Code Long Descriptor
CY 2017
Work
RVU
Proposed
CY 2018
Work
RVU
Final
CY
2018
Work
RVU
CMS Work
Time
Refinement
contrast material(s) and further sequences
73100 Radiologic examination, wrist; 2 views 0.16 0.16 0.16 No
73110 Radiologic examination, wrist; complete,
minimum of 3 views 0.17 0.17 0.17 No
73120 Radiologic examination, hand; 2 views 0.16 0.16 0.16 No
73130 Radiologic examination, hand; minimum of 3
views 0.17 0.17 0.17 No
73140 Radiologic examination, finger(s), minimum of
2 views 0.13 0.13 0.13 No
73718
Magnetic resonance (eg, proton) imaging, lower
extremity other than joint; without contrast
material(s)
1.35 1.35 1.35 No
73719
Magnetic resonance (eg, proton) imaging, lower
extremity other than joint; with contrast
material(s)
1.62 1.62 1.62 No
73720
Magnetic resonance (eg, proton) imaging, lower
extremity other than joint; without contrast
material(s), followed by contrast material(s)
and further sequences
2.15 2.15 2.15 No
74022
Radiologic examination, abdomen; complete
acute abdomen series, including supine, erect,
and/or decubitus views, single view chest
0.32 0.32 0.32 No
74018 Radiologic examination, abdomen; 1 view NEW 0.18 0.18 No
74019 Radiologic examination, abdomen; 2 views NEW 0.23 0.23 No
74021 Radiologic examination, abdomen; 3 or more
views NEW 0.27 0.27 No
74181 Magnetic resonance (eg, proton) imaging,
abdomen; without contrast material(s) 1.46 1.46 1.46 No
74182 Magnetic resonance (eg, proton) imaging,
abdomen; with contrast material(s) 1.73 1.73 1.73 No
74183
Magnetic resonance (eg, proton) imaging,
abdomen; without contrast material(s),
followed by with contrast material(s) and
further sequences
2.26 2.20 2.20 No
75635
Computed tomographic angiography,
abdominal aorta and bilateral iliofemoral lower
extremity runoff, with contrast material(s),
including noncontrast images, if performed, and
image postprocessing
2.40 2.40 2.40 No
75710 Angiography, extremity, unilateral, radiological
supervision and interpretation 1.14 1.75 1.75 No
75716 Angiography, extremity, bilateral, radiological
supervision and interpretation 1.31 1.97 1.97 No
76510
Ophthalmic ultrasound, diagnostic; B-scan and
quantitative A-scan performed during the same
patient encounter
1.55 0.70 0.70 No
76511 Ophthalmic ultrasound, diagnostic; quantitative
A-scan only 0.94 0.64 0.64 No
76512 Ophthalmic ultrasound, diagnostic; B-scan
(with or without superimposed non-quantitative 0.94 0.56 0.56 No
CMS-1676-F 426
HCPCS
Code Long Descriptor
CY 2017
Work
RVU
Proposed
CY 2018
Work
RVU
Final
CY
2018
Work
RVU
CMS Work
Time
Refinement
A-scan)
76516 Ophthalmic biometry by ultrasound
echography, A-scan 0.54 0.40 0.40 No
76519
Ophthalmic biometry by ultrasound
echography, A-scan; with intraocular lens
power calculation
0.54 0.54 0.54 No
76881 Ultrasound, extremity, nonvascular, real-time
with image documentation; complete 0.63 0.63 0.63 No
76882
Ultrasound, extremity, nonvascular, real-time
with image documentation; limited, anatomic
specific
0.49 0.49 0.49 No
77261 Therapeutic radiology treatment planning;
simple 1.39 1.30 1.30 No
77262 Therapeutic radiology treatment planning;
intermediate 2.11 2.00 2.00 No
77263 Therapeutic radiology treatment planning;
complex 3.14 3.14 3.14 No
78300 Bone and/or joint imaging; limited area 0.62 0.62 0.62 No
78305 Bone and/or joint imaging; multiple areas 0.83 0.83 0.83 No
78306 Bone and/or joint imaging; whole body 0.86 0.86 0.86 No
88184
Flow cytometry, cell surface, cytoplasmic, or
nuclear marker, technical component only; first
marker
0.00 - 0.00 No
88185
Flow cytometry, cell surface, cytoplasmic, or
nuclear marker, technical component only; each
additional marker
0.00 - 0.00 No
88333
Pathology consultation during surgery;
cytologic examination (eg, touch prep, squash
prep), initial site
1.20 1.20 1.20 No
88334
Pathology consultation during surgery;
cytologic examination (eg, touch prep, squash
prep), each additional site
0.73 0.73 0.73 No
88360
Morphometric analysis, tumor
immunohistochemistry (eg, Her-2/neu, estrogen
receptor/progesterone receptor), quantitative or
semiquantitative, per specimen, each single
antibody stain procedure; manual
1.10 0.85 0.85 No
88361
Morphometric analysis, tumor
immunohistochemistry (eg, Her-2/neu, estrogen
receptor/progesterone receptor), quantitative or
semiquantitative, per specimen, each single
antibody stain procedure; using computer-
assisted technology
1.18 0.95 0.95 No
92136
Ophthalmic biometry by partial coherence
interferometry with intraocular lens power
calculation
0.54 0.54 0.54 No
93279
Programming device evaluation (in person)
with iterative adjustment of the implantable
device to test the function of the device and
select optimal permanent programmed values
0.65 0.65 0.65 No
CMS-1676-F 427
HCPCS
Code Long Descriptor
CY 2017
Work
RVU
Proposed
CY 2018
Work
RVU
Final
CY
2018
Work
RVU
CMS Work
Time
Refinement
with analysis, review and report by a physician
or other qualified health care professional;
single lead pacemaker system
93280
Programming device evaluation (in person)
with iterative adjustment of the implantable
device to test the function of the device and
select optimal permanent programmed values
with analysis, review and report by a physician
or other qualified health care professional; dual
lead pacemaker system
0.77 0.77 0.77 No
93281
Programming device evaluation (in person)
with iterative adjustment of the implantable
device to test the function of the device and
select optimal permanent programmed values
with analysis, review and report by a physician
or other qualified health care professional;
multiple lead pacemaker system
0.90 0.85 0.85 No
93282
Programming device evaluation (in person)
with iterative adjustment of the implantable
device to test the function of the device and
select optimal permanent programmed values
with analysis, review and report by a physician
or other qualified health care professional;
single lead transvenous implantable
defibrillator system
0.85 0.85 0.85 No
93283
Programming device evaluation (in person)
with iterative adjustment of the implantable
device to test the function of the device and
select optimal permanent programmed values
with analysis, review and report by a physician
or other qualified health care professional; dual
lead transvenous implantable defibrillator
system
1.15 1.15 1.15 No
93284
Programming device evaluation (in person)
with iterative adjustment of the implantable
device to test the function of the device and
select optimal permanent programmed values
with analysis, review and report by a physician
or other qualified health care professional;
multiple lead transvenous implantable
defibrillator system
1.25 1.25 1.25 No
93285
Programming device evaluation (in person)
with iterative adjustment of the implantable
device to test the function of the device and
select optimal permanent programmed values
with analysis, review and report by a physician
or other qualified health care professional;
implantable loop recorder system
0.52 0.52 0.52 No
93286 Peri-procedural device evaluation (in person)
and programming of device system parameters 0.30 0.30 0.30 No
CMS-1676-F 428
HCPCS
Code Long Descriptor
CY 2017
Work
RVU
Proposed
CY 2018
Work
RVU
Final
CY
2018
Work
RVU
CMS Work
Time
Refinement
before or after a surgery, procedure, or test with
analysis, review and report by a physician or
other qualified health care professional; single,
dual, or multiple lead pacemaker system
93287
Peri-procedural device evaluation (in person)
and programming of device system parameters
before or after a surgery, procedure, or test with
analysis, review and report by a physician or
other qualified health care professional; single,
dual, or multiple lead implantable defibrillator
system
0.45 0.45 0.45 No
93288
Interrogation device evaluation (in person) with
analysis, review and report by a physician or
other qualified health care professional,
includes connection, recording and
disconnection per patient encounter; single,
dual, or multiple lead pacemaker system
0.43 0.43 0.43 No
93289
Interrogation device evaluation (in person) with
analysis, review and report by a physician or
other qualified health care professional,
includes connection, recording and
disconnection per patient encounter; single,
dual, or multiple lead transvenous implantable
defibrillator system, including analysis of heart
rhythm derived data elements
0.92 0.75 0.75 No
93290
Interrogation device evaluation (in person) with
analysis, review and report by a physician or
other qualified health care professional,
includes connection, recording and
disconnection per patient encounter;
implantable cardiovascular monitor system,
including analysis of 1 or more recorded
physiologic cardiovascular data elements from
all internal and external sensors
0.43 0.43 0.43 No
93291
Interrogation device evaluation (in person) with
analysis, review and report by a physician or
other qualified health care professional,
includes connection, recording and
disconnection per patient encounter;
implantable loop recorder system, including
heart rhythm derived data analysis
0.43 0.37 0.37 No
93292
Interrogation device evaluation (in person) with
analysis, review and report by a physician or
other qualified health care professional,
includes connection, recording and
disconnection per patient encounter; wearable
defibrillator system
0.43 0.43 0.43 No
93293
Transtelephonic rhythm strip pacemaker
evaluation(s) single, dual, or multiple lead
pacemaker system, includes recording with and
0.32 0.31 0.31 No
CMS-1676-F 429
HCPCS
Code Long Descriptor
CY 2017
Work
RVU
Proposed
CY 2018
Work
RVU
Final
CY
2018
Work
RVU
CMS Work
Time
Refinement
without magnet application with analysis,
review and report(s) by a physician or other
qualified health care professional, up to 90 days
93294
Interrogation device evaluation(s) (remote), up
to 90 days; single, dual, or multiple lead
pacemaker system with interim analysis,
review(s) and report(s) by a physician or other
qualified health care professional
0.65 0.60 0.60 No
93295
Interrogation device evaluation(s) (remote), up
to 90 days; single, dual, or multiple lead
implantable defibrillator system with interim
analysis, review(s) and report(s) by a physician
or other qualified health care professional
1.29 0.74 0.74 No
93296
Interrogation device evaluation(s) (remote), up
to 90 days; single, dual, or multiple lead
pacemaker system or implantable defibrillator
system, remote data acquisition(s), receipt of
transmissions and technician review, technical
support and distribution of results
0.00 0.00 0.00 No
93297
Interrogation device evaluation(s), (remote) up
to 30 days; implantable cardiovascular monitor
system, including analysis of 1 or more
recorded physiologic cardiovascular data
elements from all internal and external sensors,
analysis, review(s) and report(s) by a physician
or other qualified health care professional
0.52 0.52 0.52 No
93298
Interrogation device evaluation(s), (remote) up
to 30 days; implantable loop recorder system,
including analysis of recorded heart rhythm
data, analysis, review(s) and report(s) by a
physician or other qualified health care
professional
0.52 0.52 0.52 No
93299
Interrogation device evaluation(s), (remote) up
to 30 days; implantable cardiovascular monitor
system or implantable loop recorder system,
remote data acquisition(s), receipt of
transmissions and technician review, technical
support and distribution of results
0.00 0.00 0.00 No
93306
Echocardiography, transthoracic, real-time with
image documentation (2D), includes M-mode
recording, when performed, complete, with
spectral Doppler echocardiography, and with
color flow Doppler echocardiography
1.30 1.50 1.50 No
93307
Echocardiography, transthoracic, real-time with
image documentation (2D), includes M-mode
recording, when performed, complete, without
spectral or color Doppler echocardiography
0.92 0.92 0.92 No
93308
Echocardiography, transthoracic, real-time with
image documentation (2D), includes M-mode
recording, when performed, follow-up or
0.53 0.53 0.53 No
CMS-1676-F 430
HCPCS
Code Long Descriptor
CY 2017
Work
RVU
Proposed
CY 2018
Work
RVU
Final
CY
2018
Work
RVU
CMS Work
Time
Refinement
limited study
93350
Echocardiography, transthoracic, real-time with
image documentation (2D), includes M-mode
recording, when performed, during rest and
cardiovascular stress test using treadmill,
bicycle exercise and/or pharmacologically
induced stress, with interpretation and report;
1.46 1.46 1.46 No
93351
Echocardiography, transthoracic, real-time with
image documentation (2D), includes M-mode
recording, when performed, during rest and
cardiovascular stress test using treadmill,
bicycle exercise and/or pharmacologically
induced stress, with interpretation and report;
including performance of continuous
electrocardiographic monitoring, with
supervision by a physician or other qualified
health care professional
1.75 1.75 1.75 No
93503
Insertion and placement of flow directed
catheter (eg, Swan-Ganz) for monitoring
purposes
2.91 2.00 2.00 No
93613 Intracardiac electrophysiologic 3-dimensional
mapping 6.99 5.23 5.23 No
93668 Peripheral arterial disease (PAD) rehabilitation,
per session N 0.00 0.00 No
93792
Patient/caregiver training for initiation of home
INR monitoring under the direction of a
physician or other qualified health care
professional, including face-to-face, use and
care of the INR monitor, obtaining blood
sample, instructions for reporting home INR
test results, and documentation of
patient's/caregiver’s ability to perform testing
and report results
NEW 0.00 0.00 No
93793
Anticoagulant management for a patient taking
warfarin, must include review and
interpretation of a new home, office, or lab
International Normalized Ratio (INR) test
result, patient instructions, dosage adjustment
(as needed), and scheduling of additional test(s)
when performed
NEW 0.18 0.18 No
94617 Exercise test for bronchospasm, including pre-
and post-spirometry and pulse oximetry NEW 0.70 0.70 No
94618
Pulmonary stress testing (eg, 6-minute walk
test), including measurement of heart rate,
oximetry, and oxygen titration, when performed
NEW 0.48 0.48 No
94621
Cardiopulmonary exercise testing, including
measurements of minute ventilation, CO2
production, O2 uptake, and
electrocardiographic recordings
1.42 1.42 1.42 No
95004 Percutaneous tests (scratch, puncture, prick) 0.01 0.01 0.01 No
CMS-1676-F 431
HCPCS
Code Long Descriptor
CY 2017
Work
RVU
Proposed
CY 2018
Work
RVU
Final
CY
2018
Work
RVU
CMS Work
Time
Refinement
with allergenic extracts, immediate type
reaction, including test interpretation and
report, specify number of tests
95250
Ambulatory continuous glucose monitoring of
interstitial tissue fluid via a subcutaneous
sensor for a minimum of 72 hours; sensor
placement, hook-up, calibration of monitor,
patient training, removal of sensor, and printout
of recording
0.00 0.00 0.00 No
95251
Ambulatory continuous glucose monitoring of
interstitial tissue fluid via a subcutaneous
sensor for a minimum of 72 hours;
interpretation and report
0.85 0.70 0.70 No
95930
Visual evoked potential (VEP) testing central
nervous system except glaucoma, checkerboard
or flash, with interpretation and report
0.35 0.35 0.35 No
96160
Administration of patient-focused health risk
assessment instrument (eg, health hazard
appraisal) with scoring and documentation, per
standardized instrument
0.00 0.00 0.00 No
96161
Administration of caregiver-focused health risk
assessment instrument (eg, depression
inventory) for the benefit of the patient, with
scoring and documentation, per standardized
instrument
0.00 0.00 0.00 No
96360 Intravenous infusion, hydration; initial, 31
minutes to 1 hour 0.17 0.17 0.17 No
96361 Intravenous infusion, hydration; each additional
hour 0.09 0.09 0.09 No
96372
Therapeutic, prophylactic, or diagnostic
injection (specify substance or drug);
subcutaneous or intramuscular
0.17 0.17 0.17 No
96374
Therapeutic, prophylactic, or diagnostic
injection (specify substance or drug);
intravenous push, single or initial
substance/drug
0.18 0.18 0.18 No
96375
Therapeutic, prophylactic, or diagnostic
injection (specify substance or drug); each
additional sequential intravenous push of a new
substance/drug
0.10 0.10 0.10 No
96377
Application of on-body injector (includes
cannula insertion) for timed subcutaneous
injection
0.00 0.17 0.17 No
96401 Chemotherapy administration, subcutaneous or
intramuscular; non-hormonal anti-neoplastic 0.21 0.21 0.21 No
96402 Chemotherapy administration, subcutaneous or
intramuscular; hormonal anti-neoplastic 0.19 0.19 0.19 No
96409 Chemotherapy administration; intravenous,
push technique, single or initial substance/drug 0.24 0.24 0.24 No
96411 Chemotherapy administration; intravenous, 0.20 0.20 0.20 No
CMS-1676-F 432
HCPCS
Code Long Descriptor
CY 2017
Work
RVU
Proposed
CY 2018
Work
RVU
Final
CY
2018
Work
RVU
CMS Work
Time
Refinement
push technique, each additional substance/drug
96573
Photodynamic therapy by external application
of light to destroy premalignant lesions of the
skin and adjacent mucosa with application and
illumination/activation of photosensitizing
drug(s), per day
NEW 0.48 0.48 No
96574
Debridement of premalignant hyperkeratotic
lesion(s) (ie, targeted curettage, abrasion)
followed with photodynamic therapy by
external application of light to destroy
premalignant lesions of the skin and adjacent
mucosa with application and
illumination/activation of photosensitizing
drug(s), per day
NEW 1.01 1.01 No
96910
Photochemotherapy; tar and ultraviolet B
(Goeckerman treatment) or petrolatum and
ultraviolet B
0.00 0.00 0.00 No
97012 Application of a modality to 1 or more areas;
traction, mechanical 0.25 0.25 0.25 No
97014 Application of a modality to 1 or more areas;
electrical stimulation (unattended) 0.18 0.18 0.18 No
97016 Application of a modality to 1 or more areas;
vasopneumatic devices 0.18 0.18 0.18 No
97018 Application of a modality to 1 or more areas;
paraffin bath 0.06 0.06 0.06 No
97022 Application of a modality to 1 or more areas;
whirlpool 0.17 0.17 0.17 No
97032 Application of a modality to 1 or more areas;
electrical stimulation (manual), each 15 minutes 0.25 0.25 0.25 No
97033 Application of a modality to 1 or more areas;
iontophoresis, each 15 minutes 0.26 0.26 0.26 No
97034 Application of a modality to 1 or more areas;
contrast baths, each 15 minutes 0.21 0.21 0.21 No
97035 Application of a modality to 1 or more areas;
ultrasound, each 15 minutes 0.21 0.21 0.21 No
97110
Therapeutic procedure, 1 or more areas, each 15
minutes; therapeutic exercises to develop
strength and endurance, range of motion and
flexibility
0.45 0.45 0.45 No
97112
Therapeutic procedure, 1 or more areas, each 15
minutes; neuromuscular reeducation of
movement, balance, coordination, kinesthetic
sense, posture, and/or proprioception for sitting
and/or standing activities
0.45 0.50 0.50 No
97113
Therapeutic procedure, 1 or more areas, each 15
minutes; aquatic therapy with therapeutic
exercises
0.44 0.48 0.48 No
97116 Therapeutic procedure, 1 or more areas, each 15
minutes; gait training (includes stair climbing) 0.40 0.45 0.45 No
97127 Therapeutic interventions that focus on NEW I I Yes
CMS-1676-F 433
HCPCS
Code Long Descriptor
CY 2017
Work
RVU
Proposed
CY 2018
Work
RVU
Final
CY
2018
Work
RVU
CMS Work
Time
Refinement
cognitive function (eg, attention, memory,
reasoning, executive function, problem solving,
and/or pragmatic functioning) and
compensatory strategies to manage the
performance of an activity (eg, managing time
or schedules, initiating, organizing and
sequencing tasks, direct (one-on-one) patient
contact (do not report 97X11 in conjunction
with 0364T, 0365T, 0368T, 0369T) (report
97X11 only once per day)
97140
Manual therapy techniques (eg, mobilization/
manipulation, manual lymphatic drainage,
manual traction), 1 or more regions, each 15
minutes
0.43 0.43 0.43 No
97530
Therapeutic activities, direct (one-on-one)
patient contact (use of dynamic activities to
improve functional performance), each 15
minutes
0.44 0.44 0.44 No
97533
Sensory integrative techniques to enhance
sensory processing and promote adaptive
responses to environmental demands, direct
(one-on-one) patient contact, each 15 minutes
0.44 0.48 0.48 No
97535
Self-care/home management training (eg,
activities of daily living (ADL) and
compensatory training, meal preparation, safety
procedures, and instructions in use of assistive
technology devices/adaptive equipment) direct
one-on-one contact, each 15 minutes
0.45 0.45 0.45 No
97537
Community/work reintegration training (eg,
shopping, transportation, money management,
avocational activities and/or work
environment/modification analysis, work task
analysis, use of assistive technology
device/adaptive equipment), direct one-on-one
contact, each 15 minutes
0.45 0.48 0.48 No
97542 Wheelchair management (eg, assessment,
fitting, training), each 15 minutes 0.45 0.48 0.48 No
97760
Orthotic(s) management and training (including
assessment and fitting when not otherwise
reported), upper extremity(ies), lower
extremity(ies) and/or trunk, initial orthotic(s)
encounter, each 15 minutes
0.45 0.50 0.50 No
97761
Prosthetic(s) training, upper and/or lower
extremity(ies), initial prosthetic(s) encounter,
each 15 minutes
0.45 0.50 0.50 No
97763
Orthotic(s)/prosthetic(s) management and/or
training, upper extremity(ies), lower
extremity(ies), and/or trunk, subsequent
orthotic(s)/prosthetic(s) encounter, each 15
minutes
NEW 0.48 0.48 No
CMS-1676-F 434
HCPCS
Code Long Descriptor
CY 2017
Work
RVU
Proposed
CY 2018
Work
RVU
Final
CY
2018
Work
RVU
CMS Work
Time
Refinement
99091
Collection and interpretation of physiologic
data (eg, ECG, blood pressure, glucose
monitoring) digitally stored and/or transmitted
by the patient and/or caregiver to the physician
or other qualified health care professional,
qualified by education, training,
licensure/regulation (when applicable) requiring
a minimum of 30 minutes of time
B - 1.10 No
99483
Assessment of and care planning for a patient
with cognitive impairment, requiring an
independent historian, in the office or other
outpatient, home or domiciliary or rest home,
with all of the following required
elements:Cognition-focused evaluation
including a pertinent history and
examination;Medical decision making of
moderate or high complexity;Functional
assessment (eg, Basic and Instrumental
Activities of Daily Living), including decision-
making capacity;Use of standardized
instruments for staging of dementia (eg,
Functional Assessment Staging Test [FAST],
Clinical Dementia Rating [CDR]);Medication
reconciliation and review for high-risk
medications;Evaluation for neuropsychiatric
and behavioral symptoms, including
depression, including use of standardized
screening instrument(s);Evaluation of safety
(eg, home), including motor vehicle
operation;Identification of caregiver(s),
caregiver knowledge, caregiver needs, social
supports, and the willingness of caregiver to
take on caregiving tasks;Development,
updating or revision, or review of an Advance
Care Plan;Creation of a written care plan,
including initial plans to address any
neuropsychiatric symptoms, neuro-cognitive
symptoms, functional limitations, and referral
to community resources as needed (eg,
rehabilitation services, adult day programs,
support groups) shared with the patient and/or
caregiver with initial education and
support.Typically, 50 minutes are spent face-to-
face with the patient and/or family or caregiver.
NEW 3.44 3.44 No
99484
Care management services for behavioral health
conditions, at least 20 minutes of clinical staff
time, directed by a physician or other qualified
health care professional, per calendar month,
with the following required elements:Initial
assessment or follow-up monitoring, including
the use of applicable validated rating
NEW 0.61 0.61 No
CMS-1676-F 435
HCPCS
Code Long Descriptor
CY 2017
Work
RVU
Proposed
CY 2018
Work
RVU
Final
CY
2018
Work
RVU
CMS Work
Time
Refinement
scales;Behavioral health care planning in
relation to behavioral/psychiatric health
problems, including revision for patients who
are not progressing or whose status
changes;Facilitating and coordinating treatment
such as psychotherapy, pharmacotherapy,
counseling and/or psychiatric consultation;
andContinuity of care with a designated
member of the care team
99492
Initial psychiatric collaborative care
management, first 70 minutes in the first
calendar month of behavioral health care
manager activities, in consultation with a
psychiatric consultant, and directed by the
treating physician or other qualified health care
professional, with the following required
elements:outreach to and engagement in
treatment of a patient directed by the treating
physician or other qualified health care
professional; initial assessment of the patient,
including administration of validated rating
scales, with the development of an
individualized treatment plan; review by the
psychiatric consultant with modifications of the
plan if recommended; entering patient in a
registry and tracking patient follow-up and
progress using the registry, with appropriate
documentation, and participation in weekly
caseload consultation with the psychiatric
consultant; andprovision of brief interventions
using evidence-based techniques such as
behavioral activation, motivational
interviewing, and other focused treatment
strategies.
NEW 1.70 1.70 No
99493
Subsequent psychiatric collaborative care
management, first 60 minutes in a subsequent
month of behavioral health care manager
activities, in consultation with a psychiatric
consultant, and directed by the treating
physician or other qualified health care
professional, with the following required
elements:tracking patient follow-up and
progress using the registry, with appropriate
documentation; participation in weekly
caseload consultation with the psychiatric
consultant; ongoing collaboration with and
coordination of the patient's mental health care
with the treating physician or other qualified
health care professional and any other treating
mental health providers; additional review of
progress and recommendations for changes in
NEW 1.53 1.53 No
CMS-1676-F 436
HCPCS
Code Long Descriptor
CY 2017
Work
RVU
Proposed
CY 2018
Work
RVU
Final
CY
2018
Work
RVU
CMS Work
Time
Refinement
treatment, as indicated, including medications,
based on recommendations provided by the
psychiatric consultant;provision of brief
interventions using evidence-based techniques
such as behavioral activation, motivational
interviewing, and other focused treatment
strategies;monitoring of patient outcomes using
validated rating scales; and relapse prevention
planning with patients as they achieve
remission of symptoms and/or other treatment
goals and are prepared for discharge from
active treatment.
99494
Initial or subsequent psychiatric collaborative
care management, each additional 30 minutes in
a calendar month of behavioral health care
manager activities, in consultation with a
psychiatric consultant, and directed by the
treating physician or other qualified health care
professional
NEW 0.82 0.82 No
G0283
Electrical stimulation (unattended), to one or
more areas for indication(s) other than wound
care, as part of a therapy plan of care
0.18 0.18 0.18 No
G0513 Prolonged preventive service(s), initial 30
minutes NEW 1.17 1.17 No
G0514 Prolonged preventive service(s), first 30
minutes NEW 1.17 1.17 No
G0515
Development of cognitive skills to improve
attention, memory, or problem solving
(includes compensatory training), direct one-
on-one patient contact, each 15 minutes
NEW 0.44 0.44 No
G0516 Insertion, non- biodegradable drug delivery
implants, 4 or more NEW 1.82 1.82 No
G0517 Removal, non- biodegradable drug deliver
implants, 4 or more NEW 2.10 2.10 No
G0518 Removal with reinsertion, non-biodegradable
drug delivery implants, 4 or more NEW 3.55 3.55 No